1 Single isolated cells were obtained from the taenia of the guinea-pig's caecum by enzymic digestion and held under voltage clamp. The effects of various catecholamines, sympathomimetics and related compounds were tested for their ability to potentiate the voltage-dependent calcium current (ICa) evoked in these cells by a depolarizing step. 2 ICa was potentiated by up to 60% by isoprenaline, adrenaline, and noradrenaline which were equipotent. The EC50 for isoprenaline was about 40 nM. 3 The racemic mixtures of the optical isomers of isoprenaline, adrenaline, and noradrenaline, and (+)-isoprenaline, were equipotent with the (-)-isomers of these drugs. Dopamine, L-dopa, and catechol were equipotent with these catecholamines. 4 Removal or substitution of one or more of the hydroxy groups of the catechol moiety, as in phenylephrine, salbutamol, procaterol, methoxamine, terbutaline, BRL 37344, ICI 215001 or tyramine substantially reduced efficacy and/or potency. 5 The adrenoceptor blockers propranolol, phentolamine, dihydroergotamine, atenolol, CGP 20712A and ICI 118551, or the dopamine receptor blockers, haloperidol or flupenthixol, did not block the potentiating action of catechol or the catecholamines. 6 The receptor activated by catecholamines to increase ICa we suggest should be called a C-receptor in view of its sensitivity to catechol. It may arise by enzymic modification of a conventional adrenoceptor but its transduction also involves a novel mechanism which might indicate that it is present in the muscle cells before enzyme treatment.
Introduction
The structure of the voltage-dependent calcium channel of smooth muscles shows considerable similarities to that of the cardiac channel (Biel et al., 1990; Koch et al., 1990) . However, PI-adrenoceptor activation in heart increases the force of cardiac contraction and increases the calcium current ('Ca) by activation of an adenosine 3':5'-cyclic monophosphate (cylic AMP)-dependent kinase and phosphorylation of the channel (Kameyama et al., 1985; 1986) whereas in smooth muscle P2-adrenoceptor activation causes relaxation and generally hyperpolarization (see Bulbring & Tomita, 1987) . Despite this, P-adrenoceptor activation in tracheal smooth muscle (Welling et al., 1991; and in smooth muscle cells from pig coronary artery (Fukumitsu et al., 1990) has been reported to increase ICa as PI-receptor activation does in heart.
Although cyclic AMP-dependent phosphorylation of calcium channels is believed to be responsible for the increase in ICa in heart, we have found activators of adenyl cyclase, cyclic AMP, or its analogues, did not mimic the potentiation of ICa produced by isoprenaline in smooth muscle cells from the guinea-pig taenia caeci (Muraki et al., 1993) . This result is similar to that of Ohya et al. (1987) who found that cyclic AMP did not potentiate ICa in cells from the longitudinal smooth muscle of rabbit jejunums in contrast to results in pig coronary artery smooth muscle where forskolin potentiated ICa (Fukumitsu et al., 1990) . We have also found that potentiation of ICa in guinea-pig taenia cells did not appear to be mediated by a G-protein, contrary to results obtained in tracheal smooth muscle by Welling et al. (1991; or to be mediated by activation of protein kinase C which has been implicated in the increase in ha produced by muscarinic and and other receptor activation in amphibian gastric smooth muscle cells (Vivaudou et al., 1988) . I Author for correspondence.
The actions of noradrenaline (NA), adrenaline (Ad) and other sympathomimetics on smooth and cardiac muscles have been intensively investigated since the pioneer work of Barger & Dale (1910) . Around the time of identification of NA as the main, or as an important, transmitter at sympathetic nerve endings (von Euler, 1946) and Ad as the main hormone released from the adrenal medulla (Biilbring, 1949; Bulbring & Burn, 1949 ) the subdivision of adrenoceptors into a-and P-subtypes on the basis of the relative potencies of some sympathomimetic amines was proposed (Ahlquist, 1948) . The characteristics of the molecule which confer ability to activate presently known adrenoceptors are the 3:4 dihydroxybenzene moiety and the aliphatic side chain of two carbon atoms (P and a) which terminates in an amino group (Barlow, 1964) . P-Hydroxylation further intensifies activity but catechol itself is without sympathomimetic activity (Barger & Dale, 1910) . Since Ahlquist's division into two groups, adrenoceptors have been further subdivided into a, and M2 (Dubocovitch & Langer, 1974; Drew & Whiting, 1979 ) and P1, P2 and 'atypical' P3 varieties (Lands et al., 1967; Bond & Clarke, 1987; Hollenga & Zaagsma, 1989) .
We noticed that NA, Ad and isoprenaline (Iso) were all able to increase ICa in guinea-pig taenia single cells under voltage clamp (Muraki et al., 1993) . NA and Ad also increased ICa in smooth muscle cells from rabbit ear artery (Benham & Tsien, 1988) . In cultured aortic smooth muscle (Serebryakov & Takeda, 1992) NA or Ad decreased ICa. In both these last two tissues the receptors through which NA and Ad produced these effects were not blocked by a-or by P-adrenoceptor blockers. It was therefore decided to characterize the adrenoceptors which mediated the increase in lCa in cells of the taenia caeci of the guinea-pig. In this tissue, Ad or NA inhibit contraction and relax the muscle (Burnstock, 1958;  Bulbring & Tomita, 1969) through actions on both a-'." Macmillan Press Ltd, 1994 (BUlbring & Tomita, 1969 and P-adrenoceptors (BuIbring & den Hertog, 1980) . Single cells were used because we wished to examine the possibility that activation of adrenoceptors modulated ICa in these cells, and because when adrenoceptor stimulants are applied to a whole tissue, actions on one type of mechanism may be obscured by other actions on other mechanisms especially if only tension is recorded.
Methods

Preparation of cells
Guinea-pigs of either sex, weighing 200-400 g were killed by stunning and exsanguination and small pieces of taenia from the caecum were dissected. After fat and connective tissues were removed under a binocular microscope, 10-20 mm x 0.5-1.0 mm pieces of taenia were immersed in Ca2" and Mg2"-free physiological salt solution (Ca2"-Mg2" free solution for 10 min. They were then incubated for 15 min in the Ca2+-Mg2+ free solution which contained 1 mg ml-' collagenase and 0.5 mg ml-' pronase using a similar method to that previously described (Inoue & Isenberg, 1990; Pacaud & Bolton, 1991) . After that, the solution was changed to enzyme-free fresh Ca2+-Mg2+ free solution and the pieces agitated gently. Then cells were spun down at 1000 r.p.m. for 2 min, resuspended in low-Ca2" physiological salt solution which contained 0.55 mM Ca2+, and stored at 40C until use on the same day.
Membrane current measurements
Membrane currents were recorded with standard whole-cell voltage-clamp methods (Hamill et al., 1981) using a List-EPC 5 patch clamp amplifier using pipettes which had 3 to 5 MC resistance. No correction for leakage currents was made. Voltage steps were produced by a command generated by a BBC microcomputer linked through a CED 1401 interface (Cambridge Electronic Devices, Cambridge, U.K.). Current signals were stored on FM tape (Racal) and later captured on a BBC micro computer using the CED 1401 and our own capturing program for precise analysis. All experiments were carried out at 22 ± 20C.
Solutions
Experiments were conducted in physiological salt solution (PSS) containing (mM): NaCl 137, KCl 6, MgCl2 1.2, CaCl2 2.2, glucose 10 and HEPES 10. Ca2" and Mg2+-free solution for dispersing cells contained (mM) NaCl 128, KCI 6, glucose 10 and HEPES 10. The pH of these solutions was adjusted to 7.4 using NaOH. The composition of standard pipette solution was (mM): CsCl 140, MgCl2 1, ATP-2Na 2, GTP-3Na 0.3, HEPES 10 and EGTA 4 (titrated to pH 7.4 with CsOH). Drugs ( ± )-and (-)-adrenaline, catechol, L-P-3,4-dihydroxyphenylalanine (L-dopa), dihydroergotamine methane sulphonate, dopamine hydrochloride, isoetharine mesylate, haloperidol, (± )-isoprenaline hydrochloride, (-)and (+)-isoprenaline bitartrate, methoxamine hydrochloride, (-)and (±)-noradrenaline hydrochloride, phentolamine hydrochloride, (-)phenylephrine hydrochloride, procaterol hydrochloride, (-)propranolol hydrochloride, salbutamol hemisulphate, terbutaline hemisulphate, tyramine hydrochloride (all from Sigma). 1-[2-((3-Carbomoyl-4-hydroxy)phenoxy)ethylamino]-3-[4-(1-methyl-4-trifluoromethyl-2-imidazolyl) phenoxy]-propan-2-ol methane sulphonate (CGP 20712A, Ciba Geigy), 4-[2-[(2-hydroxy-2-(3-chlorophenyl) ethyl) amino] propyl]-phenoxyacetic acid (BRL 37344, SmithKline Beecham), erythro-DL -1 -(7 -methylindan -4-yloxy)-3-isopropylaminobutan-2 -ol hydrochloride (ICI 118551, Cambridge Research Biochemicals), ICI 215001 (M 215001, metabolite of D7114, ICI-Zeneca) , cis(z)-flupenthixol hydrochloride (Research Biochemicals).
Results
Cells were held at -50 mV and depolarized for 200 ms to 0 mV every 20 s. This evoked an inward current carried by calcium ions ('Ca) which was not significantly contaminated by potassium currents due to the use of caesium chloride instead of potassium chloride in the pipette solution. The peak size of the evoked inward current was measured. Drugs were applied for short periods until any change in the peak size of the current had stabilized; the effect of a drug was sometimes expressed as a change in the size of the current relative to the size of the current immediately before drug application. Because current size often increased without drug application for several minutes after beginning recording in the whole-cell mode, the first response to drug application was sometimes less reliable.
It was found that NA, Ad or isoprenaline (Iso) increased the size of the voltage-dependent current and although this effect varied in size in different cells a 60% increase was not uncommon (Figure la,b ). Because the potentiation could be produced by Iso it was suspected that the effect was mediated by P-receptors but an unexpected finding was that P-receptor antagonists such as propranolol up to 10WpM had no inhibitory effect ( Figure 3a ). Therefore, further experiments were made in order to characterize the adrenoceptor involved.
It was observed that the racemates of NA, Ad and Iso were about equipotent (Figure la-c). This observation immediately suggested that the adrenoceptor involved was not either an aor a P-subtype as NA is invariably much more potent at a-receptors than Iso and vice-versa at P-receptors (Barlow, 1964) . The EC50 for (-)-Iso was 41 nM (n = 1-13) (Figure lef) and for ( ± )-Iso it was 42 nM ; for NA and Ad it was 24 nM (n = 1-5) and 58 nM (n = 1-7) respectively.
Those catecholamines with a P-OH group can exist as two isomers (-) and (+). At a and at 13-receptors the (-)-isomer of Ad and NA is usually 10-100 times more potent than the (+)-isomer and at 13-receptors in the case of (-)-and (+)isoprenaline, this ratio is even greater (Barlow, 1964) . The importance of the P-OH group for activity suggests that it is involved in binding at a-and at P-receptors. However, (-)-, (+)-and (±)-isoprenaline (Figure 2a ), (-)and (± )-noradrenaline, and (-)and (± )-adrenaline were equipotent; in these experiments equal concentrations of the catecholamines were applied successively to the same cell and the ratio of the increases in Ca current calculated. No ratio was significantly different from unity (Table 1) ( Figure Ic ). This result suggested that the P-OH group was unimportant for binding at this receptor. This was confirmed when experiments showed that dopamine which lacks a P-hydroxy group was equipotent with the other catcholamines examined ( Figure Id) ( Table 1) .
The structure-activity relationship was more systematically investigated; (-)-phenylephrine, and ( ± )-methoxamine, normally agonists at a-adrenoceptors (Barlow, 1964) were of low efficacy and/or were more than a thousand times less potent than NA (Figure lb,c). (± )-Salbutamol had a tenth to a hundredth of the potency, and procaterol about a thirtieth to a thousandth of the potency of NA or Iso (Figure 2e and Table 1 ), although relative potency was not reliable as these drugs were partial agonists (Figure 2b,e and Table 1 ). (± )-Salbutamol has about a sixth of the potency of ( )-Iso at P2-adrenoceptors but negligible activity at P1-adrenoceptors (Brittain et al., 1973) . ( ± )-Salbutamol is interesting because the 3-OH is replaced by 3-CH2OH. However, ( ± )-procaterol is more potent than ( ± )-salbutamol at PI and P2 receptors (Yabuuchi, 1977) whereas in the present experiments the opposite was found. relative current amplitudes before and during application of (-)-Iso, [(-)-Iso] is the concentration of (-)-Iso and KD its apparent dissociation constant. The Hill coefficient was assumed to be one and the maximum relative increase in Icon A = 0.615. KD was calculated to be 41 nm Drugs were prepared immediately before use and were applied externally by replacement of external solution by drug-containing one. Figure 2 Effects of some sympathomimetic amines, P2 (salbutamol and procaterol) and P3 agonists (BRL 37344 and ICI 215001) and catechol itself on Ic.. (-)-Isoprenaline ((-)-Iso), (+)-Iso, L-Dopa and catechol (a, c, d) equally potentiated IC, However, BRL 37344 (BRL) and ICI 215001 had a very small effect on Ice (b,e). Salbutamol and procaterol had some effects on IC. but the potentiation was smaller than that produced by Iso in the same cells (b,e). Insets show superimposed current traces before and during application of drugs. In first and second traces of (d), current traces before and during application of 3 AM (-)-Iso, or 3 AM catechol, and in the presence of both 3 LM (-)-Iso and 3 gM catechol, were superimposed; (e) Summarises results of application of salbutamol, procaterol, BRL 37344 and ICI 215001 to the indicated number of cells (open columns); in each case (-)-Iso was applied at the concentration indicated to the same cells (solid columns). Some other compounds tried had very low efficacy and/or low potency. (± )-Terbutaline which resembles Iso except that 4-OH is replaced by 5-OH was more than a 1000 times less potent than (-)-Iso, emphasising the importance of the 3-OH, 4-OH catechol nucleus for activity. BRL 37344 (12) and ICI 215001 (M 215001), the active acid metabolite of ICI D7114 (Growcott et al., 1992) , both 133-receptor agonists, were virtually inactive (Figure 2b and 2e ). The N-substitute on the molecule was clearly not important for activity at this receptor either since Iso, Ad and NA (or ± forms) were equipotent (Table 1) . Further, ( ± )isoetharine which resembles Iso except for an a-ethyl group was also equipotent (Table 1) ( Figure Id) . These results taken with those concerning the P-OH group suggested that the receptor was indifferent to the nature of the aliphatic tail. This was confirmed as L-Dopa, which has an a-COOH and b Time (s, after rupture of cell-membrane) Substances marked § were partial agonists (maximum response less than 25-30% of maximum response to Iso). Other compounds of low potency may also be partial agonists but high enough concentrations were not tested and their relative potencies were calculated by extrapolating the concentration-effect curve and assuming it was parallel with the curve for (-)-Iso or ( ± )-Iso. The potency of catechol or drugs containing a catechol nucleus was obtained by application of equal concentrations (usually 30 or 100 nM) to the same cell of the drug and (-)-Iso or ( ± )-Iso (which were assumed equipotent as EC50s were 41.8 and 41.3 nm, see text). The relative sizes of the responses were then calculated for the indicated number of cells; none proved significantly different from unity at P< 0.05. The structure of the drug, and the adrenoceptor at which it has a major action are also shown. no P-hydroxy group, was also equipotent with the catecholamines (Table 1, Figure 2a ).
It was therefore predicted that catechol (3,4,dihydroxybenzene) should be active at this receptor. This was confirmed; freshly made solutions (catechol is somewhat unstable) indicated that catechol and catecholamines were equipotent (Figure 2c,d) . Furthermore, when maximum potentiation of the current was produced by 3 gM (-)-Iso, 3 gM catechol had no effect; in the same way 3 JM (-)-Iso was without effect if 3 AM catechol had potentiated the current (Figure  2d ,f).
Various adrenoceptor blocking agents were applied to test for their antagonism at this receptor. All of these were without effect if the potentiation by Iso or other catecholamine was expressed as a percentage or fractional increase in basal current size before application of the agonist. When expressed in this way, high concentrations of antagonists had no effect on the increase in size of the current produced by (-)-Iso but generally depressed basal calcium current size themselves. (-)-Propranolol up to 10 JM was without significant antagonism; this drug has a high affinity for type PBand type P2-receptors, its pA2 being in the range 8-9 Wilson et al., 1984) although its affinity for P3receptors is somewhat less, pA2 about 7 Bond & Clarke, 1988) . Atenolol, a. Pi-selective antagonist with a pA2 of 6 to 7 (O'Donnell & Wanstall, 1983) , the PI-selective antagonst CGP 20712A with a pA2 greater than 9 (Kaumann, 1986) , and the antagonist ICI 118551 with a pA2 for P2-receptors in the range 8-10 (O'Donnell & Wanstall, 1983; in concentrations up to 10 .M did not significantly antagonize the effect of (-)-Iso or (-)-NA on ICa (Figure 3a,b,c) . Phentolamine and dihydroergotamine are generally regarded as blockers of both (, and a2 receptors with pA2 values in the range 7-8 (Barlow, 1964; Borowski et al., 1977) . These agents showed some tendency at concentrations of 3-1O M to potentiate the increase in the Ca current produced by catecholamines (Figure 3f ) and responses were often obtained in their presence (Figures lb-e, 2a-d, 3a-e ).
The a-agonist, phenylephrine (1O tiM), applied when ICa was already potentiated by 3 JAM Iso, depressed ICa; carbachol (10 ftM) applied under similar conditions also depressed ICa (not shown).
The increase in Ca current produced by dopamine or by Iso was also unaffected by the dopamine receptor antagonists haloperidol (1 JAM) and flupenthixol (1 JAM) (Figure 3d,e) . At DI and D2 dopamine receptors their pA2 is normally in the range 7-8 (Hilditch & Drew, 1985) . At higher concentrations than 1 JIM these two antagonists produced strong depression of the voltage-dependent Ca current themselves and 3 JM haloperidol virtually abolished it.
The effects of Iso, NA and catechol on tension in small strips of taenia in normal solution or when contracted by raising the potassium concentration to 20 or 40mM were examined. Phentolamine (3 JAM), propranolol (3 jAM) and atropine (3 AM) were added to the bathing solution. Since these blockers in combination did not block C-receptors, any effects of Iso on tension might be mediated by these receptors. In normal solution, taenia strips showed spontaneous contractions of several g amplitude at a frequency of about 1 every 2min, from time to time contractions spontaneously ceased. In the presence of blockers, Iso (10-7 M; four preparations, eight applications) or, NA (1-3 x 10-7m; four preparations, five applications) did not alter the pattern of activity or increase the tension developed during spontaneous contractions. In preparations contracted in high-K solutions, Iso (1-3 x 10-7 M; seven preparations, 18 applications) NA (0.3-1 X 10-6 M; four preparations, six applications) or catechol (0.3-1 X 10-6 M; three preparations, four applications) did not increase tension and sometimes a small fall was observed, presumably due to incomplete blockade of atand P-receptors. Thus, no increases in tension, indicative of increased entry of calcium through voltage-dependent channels were seen when any of the three catechols were added to preparations where a-and P-adrenoceptors and muscarinic receptors were blocked. 
Discussion
The lack of effect of any of the antagonists indicate that the receptor which mediates the increase in the voltage-dependent calcium current in response to catecholamines is not an aor a P-adrenoceptor nor is it a DI or D2 dopamine receptor. This adrenoceptor showed unusual structure-activity relationships in that the presence of a catechol nucleus was essential for full activity and altering the position of one of the -OH groups on the benzene ring, or removing one or both of these, produced drastic reductions in potency and/or efficacy. However, this receptor was indifferent to the presence of the ethylamine side chain and so catechol was equipotent with L-dopa, dopamine, Ad, Iso and NA. The P-OH group was inessential and (-)and (+)-isomers of Iso and (-) and (±)-isomers of NA and Ad were equipotent. An amino group was also without effect. In these latter two respects, this receptor differs from a-and P-adrenoceptors where the presence of a (-)-p-OH group substantially increases potency; at the ,-receptor, N-substitution with isopropyl substantially increases potency. The sensitivity to catechol would suggest that it should be called a C-receptor.
The C-receptor shows several similarities to and some differences from the adrenoceptors, activation of which modulate ICa in various enzymatically dissociated smooth muscle cells. In smooth muscle cells of rabbit ear artery, NA and Ad were equipotent in increasing ICa although Iso was ineffective; propranolol, prazosin and phentolamine were ineffective as blockers as in taenia (Benham & Tsien, 1988) . However, in smooth muscle cells from rabbit ear artery both NA and Iso have been reported by other investigators to reduce ICa; the effects of NA and Iso were found to be unaffected by propranolol and phentolamine respectively (Droogmans et al., 1987) . In smooth muscle cells of pig coronary artery, NA and Iso were equipotent but the potentiation they produced was blocked by propranolol but not by phentolamine (Fukumitsu et al., 1990) . The reduction of ICa produced by NA in cultured aortic cells was unaffected by prazosin, phentolamine or propranolol (Serebryakov & Takeda, 1992) . In rat portal vein single smooth muscle cells, the action of NA to increase ICa was blocked by phentolamine (Pacaud et al., 1987) and in guinea-pig vas deferens the reduction of ICa produced by NA or phenylephrine was blocked by prazosin and less well by yohimbine (Imaizumi et al., 1991) . In bovine tracheal smooth muscle cells, Iso increased internal free calcium activity (measured by fura 2-AM) and this effect was blocked by propranolol (0.1 M) but not by prazosin or yohimbine (at 10 JM) (Felbel et al., 1988) .
The action of Iso was on calcium influx into the cell, which was blocked by nitrendipine or methoxyverapamil (D600); the calcium influx presumably corresponds to Ic. studied in single cells by electrophysiological techniques (Welling et al., 1991; . However, the action of Iso in raising intracellular calcium activity is not confined to single, enzymedigested, cells as it has been observed in strips of tracheal smooth muscle (Takuwa et al., 1988) .
It is tempting to suggest that as adrenoceptors of unusual pharmacology have been described in single enzymically dissociated cells, that the enzyme treatment has modified the adrenoceptors involved. This impression might be reinforced by our failure to detect any effects of Iso on tension in strips of taenia when a-and P-adrenoceptors were blocked. The actions of isoprenaline and other catecholamines have been studied on the electrical activity of the guinea-pig taenia by means of both microelectrode recording and sucrose-gap techniques. Catecholamines through an action on P-receptors (blocked by propranolol) inhibit the generation of the pacemaker potential (Builbring & Tomita, 1969) and cause weak hyperpolarization (Bulbring & den Hortog, 1980) . These effects are associated with inhibition of contractile activity, or relaxation, never contraction or increase in the force of contraction; a-receptor activation causes hyperpolarization and relaxation also (Bulbring & Tomita, 1987) . However, Iso can raise internal calcium activity (Ca,) in tracheal smooth muscle strips as well as reducing the rise in Cai engendered by carbachol and this effect is mimicked by forskolin (Takuwa et al., 1988) . In the basilar artery of young rats, Iso elicits a depolarization instead of its usual hyperpolarization and this is a P-receptor effect; also NA and on occasions Iso can elicit a depolarization resistant to both aand P-adrenoceptor blockers (Byrne et al., 1985) . Responses evoked by 'y-receptors' in rat basilar artery segments required high (mM) concentrations of catecholamines, but like the responses evoked in our present experiments, NA, Ad, and dopamine had similar potency and isomers of NA and Ad were equiactive (Hirst et al., 1982) . The low concentrations of catecholamines which were effective (EC50 about 40 nM) in the present experiments are in contrast to those required to activate the fy-receptor of rat basilar artery which are four orders of magnitude higher (Hirst et al., 1982) . Thus receptors for catecholamines have been described on whole tissues which have unusual pharmacology and which may be related to the C-receptor described here. It is conceivable that the Creceptor exists in the whole tissue but its effects at the level of tension generation are for some reason not detectable.
If the C-receptor represented an a-or a P-adrenoceptor altered by collagenase and pronase treatment then it raises questions concerning the nature of the receptor binding site. The modification would represent presumably the removal of some enzyme-sensitive portion of the receptor molecule either directly or indirectly resulting in changes in the molecular architecture of the binding site. It would raise the possibility that receptors, like ion channels (e.g. Hescheler & Trautwein, 1988; Obejero-Pas et al., 1991) might be deliberately modified by enzymic treatment which might allow investigation of the parts of the receptor involved in ligand binding, or perhaps even enzymic alteration of the structure-activity relationships of identified receptors with a view to making them susceptible to novel drugs or ligands.
It is curious, that, if the C-receptor should be a modified P-receptor, that the affinity for propranolol should be so severely reduced since it implies that binding of the naphthalene group to the catechol site is weak such that loss of the hydroxyethylamine binding site(s) results in very low affinity. Nevertheless, the catechol binding site alone was sufficient for retention of considerable affinity for Iso and other catechols since they were reasonably potent. An alternative possibility is that enzymic modification of the molecule causes a binding site for catechols to be revealed, or even to be created, by exposing some juxtaposition of charged groups previously inaccessible within the molecule. A surprising fact, however, is that the activated receptor retains (or perhaps gains) the ability to alter calcium channel function. Unlike a variety of other receptors activation of which alters Ic, in smooth muscles (see Muraki et al., 1993 for references) Creceptor activation was linked to changes in calcium channel activity by a mechanism which did not seem to involve a G-protein, cyclic AMP/adenyl cyclase, or protein kinase C (Muraki et al., 1993) i.e. not only is the C-receptor novel but its transduction mechanism is also. It may be that the Creceptor is an integral part of the voltage-dependent calcium channel but, if so, it seems a separate site from that at which Bay K 8644, a dihydropyridine, binds to increase Ica because the latter increased Ic, in the occasional cell which was unresponsive to catecholamine (Muraki et al., 1993) .
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